SG10201705118RA - Dna element having the activity of enhancing foreign gene expression - Google Patents

Dna element having the activity of enhancing foreign gene expression

Info

Publication number
SG10201705118RA
SG10201705118RA SG10201705118RA SG10201705118RA SG10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA
Authority
SG
Singapore
Prior art keywords
activity
gene expression
foreign gene
dna element
enhancing foreign
Prior art date
Application number
SG10201705118RA
Inventor
Nishimiya Daisuke
Inoue Tatsuya
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SG10201705118RA publication Critical patent/SG10201705118RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • C12N2800/107Plasmid DNA for vertebrates for mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/46Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201705118RA 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression SG10201705118RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010154782 2010-07-07

Publications (1)

Publication Number Publication Date
SG10201705118RA true SG10201705118RA (en) 2017-07-28

Family

ID=44630215

Family Applications (4)

Application Number Title Priority Date Filing Date
SG2014009187A SG2014009187A (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG10201705118RA SG10201705118RA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG10201505354PA SG10201505354PA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2012094330A SG186788A1 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2014009187A SG2014009187A (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10201505354PA SG10201505354PA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2012094330A SG186788A1 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Country Status (14)

Country Link
US (3) US9371543B2 (en)
EP (3) EP2684961B1 (en)
JP (2) JP5859988B2 (en)
KR (3) KR101856927B1 (en)
CN (3) CN103080321A (en)
AU (3) AU2011274864B2 (en)
BR (1) BR112012033780A2 (en)
CA (2) CA2916937A1 (en)
ES (3) ES2701091T3 (en)
IL (1) IL243763A0 (en)
RU (1) RU2013104989A (en)
SG (4) SG2014009187A (en)
TW (2) TW201604280A (en)
WO (1) WO2012005378A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101856927B1 (en) * 2010-07-07 2018-05-10 다이이찌 산쿄 가부시키가이샤 Dna element having the activity of enhancing foreign gene expression
SG11201402476XA (en) * 2011-11-28 2015-02-27 Daiichi Sankyo Co Ltd Promoter derived from human gene
EP3521428A4 (en) * 2016-10-03 2020-06-24 Daiichi Sankyo Company, Limited PROMOTER OF Hspa5 GENE
CN107881174B (en) * 2017-11-22 2022-06-03 张宝会 Method for regulating and controlling translation level gene expression and application
AU2020447192A1 (en) * 2020-05-11 2023-01-19 Samsung Bioepis Co., Ltd. Human genome-derived polynucleotide and method for producing polypeptide of interest using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA891067B (en) * 1988-02-12 1990-04-25 Commw Scient Ind Res Org Pox virus vectors
US20070161003A1 (en) * 2003-09-29 2007-07-12 Morris David W Novel therapeutic targets in cancer
EP2105742A1 (en) * 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
JP5344682B2 (en) * 2008-12-26 2013-11-20 グローブライド株式会社 Fishing line guide and manufacturing method of fishing line guide
KR101856927B1 (en) * 2010-07-07 2018-05-10 다이이찌 산쿄 가부시키가이샤 Dna element having the activity of enhancing foreign gene expression
SG11201402476XA (en) * 2011-11-28 2015-02-27 Daiichi Sankyo Co Ltd Promoter derived from human gene

Also Published As

Publication number Publication date
ES2565428T3 (en) 2016-04-04
AU2018200686A1 (en) 2018-02-22
US11060108B2 (en) 2021-07-13
AU2016203681B2 (en) 2018-04-19
ES2701091T3 (en) 2019-02-20
US20190345515A1 (en) 2019-11-14
JP2016054741A (en) 2016-04-21
JP5859988B2 (en) 2016-02-16
CN103865931B (en) 2018-10-02
KR101920187B1 (en) 2018-11-19
SG10201505354PA (en) 2015-08-28
WO2012005378A2 (en) 2012-01-12
US20130171694A1 (en) 2013-07-04
ES2564227T3 (en) 2016-03-21
RU2013104989A (en) 2014-08-20
JP6039048B2 (en) 2016-12-07
CN105950621B (en) 2019-07-30
WO2012005378A3 (en) 2012-04-12
TWI507523B (en) 2015-11-11
AU2016203681A1 (en) 2016-06-23
CA2804381C (en) 2016-03-22
CN105950621A (en) 2016-09-21
EP2684961A1 (en) 2014-01-15
AU2018200686B2 (en) 2020-02-13
EP2591113B1 (en) 2016-01-20
EP3026117A1 (en) 2016-06-01
IL243763A0 (en) 2016-04-21
AU2011274864A1 (en) 2013-02-07
CA2916937A1 (en) 2012-01-12
CA2804381A1 (en) 2012-01-12
EP2684961B1 (en) 2016-01-20
US9371543B2 (en) 2016-06-21
KR101856927B1 (en) 2018-05-10
KR20180021247A (en) 2018-02-28
KR20180021246A (en) 2018-02-28
TW201604280A (en) 2016-02-01
CN103865931A (en) 2014-06-18
SG186788A1 (en) 2013-02-28
CN103080321A (en) 2013-05-01
US10407694B2 (en) 2019-09-10
TW201207103A (en) 2012-02-16
EP3026117B1 (en) 2018-09-12
SG2014009187A (en) 2014-04-28
US20160333371A1 (en) 2016-11-17
AU2011274864B2 (en) 2016-10-06
JP2013531967A (en) 2013-08-15
KR20130111514A (en) 2013-10-10
EP2591113A2 (en) 2013-05-15
BR112012033780A2 (en) 2016-05-31
KR101833570B1 (en) 2018-03-02

Similar Documents

Publication Publication Date Title
SI2612917T1 (en) Antisense nucleic acid
HK1198704A1 (en) Dna polymerases with improved activity dna
EP2791159A4 (en) Modified nucleic acids, and acute care uses thereof
EP2632260A4 (en) Leucine-rich repeat kinase enzyme activity
HK1207880A1 (en) Improved enzyme variants
EP2599866A4 (en) Novel nucleic acid having adjuvant activity and use thereof
EP2487238A4 (en) Hair shape susceptibility gene
GB201004475D0 (en) Gene silencing
EP2554667A4 (en) Novel cellulase gene
HK1188608A1 (en) Dna expression construct dna
EP2649993A4 (en) Stabilizer of acetaminophen
IL226536A (en) Targeted alteration of dna
IL243763A0 (en) Dna element with foreign gene expression enhancement activity and uses thereof
GB2502195B (en) Purification of nucleic acids
EP2451976A4 (en) Nucleic acid nano-biosensors
IL226537A (en) Targeted alteration of dna with oligonucleotides
HK1199064A1 (en) Promoter derived from human gene
EP2702999A4 (en) Brain-targeting functional nucleic acid and use thereof
EP2536741A4 (en) Gene fusion targeted therapy
EP2616813A4 (en) Host supported genetic biosensors
EP2535415A4 (en) Modified nucleotide molecules of xylanase and application thereof
GB201021720D0 (en) Gene variant
GB201010471D0 (en) Gene variant
GB201215484D0 (en) Optical characterisation of DNA and/or RNA
HK1201420A1 (en) Use of amylase enzyme